AMCP Nexus 2019 Street Team

At AMCP 2019, C.E. (Gene) Reeder, RPh, PhD, director of outcomes research at the University of South Carolina, sheds light on the specialty drug category and the state of pharma rebate contracting.

Videos

AMCP 2019 Street Team: C.E. (Gene) Reeder of University of South Carolina

At AMCP 2019, Cate Lockhart, MS, PharmD, PhD, executive director at Biologics and Biosimilars Collective Intelligence Consortium, discusses accelerating the uptake of biosimilars in the U.S. market.

AMCP 2019 Street Team: Cate Lockhart of Biologics and Biosimilars Collective Intelligence Consortium

At AMCP 2019, Kenneth Schaecher, MD, associate chief medical officer, University of Utah Health Plans, Salt Lake City, addresses the challenges of value-based outcomes measurement.

AMCP 2019 Street Team: Kenneth Schaecher, MD, University of Utah Health Plans

At AMCP 2019, Jann R. Rigell, RPh, MBA, principal, Enterprise Specialty Programs, MedImpact Direct, shares strategies to rein in specialty drugs costs.

Author | AMCP Nexus 2019 Street Team

Articles

AMCP 2019 Street Team: C.E. (Gene) Reeder of University of South Carolina

AMCP 2019 Street Team: Cate Lockhart of Biologics and Biosimilars Collective Intelligence Consortium

AMCP 2019 Street Team: Kenneth Schaecher, MD, University of Utah Health Plans

AMCP NEXUS 2019 Street Team: Jann R. Rigell of MedImpact Direct